Cross Country Healthcare Bets on AI After Steep 2025 Losses
- 2025 Revenue: $1.05 billion, down 22% from 2024
- 2025 Net Loss: $94.9 million, up from $14.6 million in 2024
- AI Platform Usage: Intellify® processed 5.7 million hours in 2025
Experts would likely conclude that Cross Country Healthcare faces significant challenges due to industry-wide staffing declines and a failed merger, but its strategic pivot to AI and cost-cutting measures could position it for a recovery in 2026.
Cross Country Healthcare Bets on AI After Steep 2025 Losses
BOCA RATON, FL – March 04, 2026 – Cross Country Healthcare (Nasdaq: CCRN) revealed a challenging financial picture for 2025, posting significant revenue declines and a substantial net loss exacerbated by the fallout from a terminated merger. Despite the turbulent year, the company is signaling a strategic pivot, banking on its proprietary AI technology, aggressive cost-cutting, and a robust balance sheet to navigate a market in transition and engineer a comeback in 2026.
The healthcare workforce solutions company announced full-year 2025 revenue of $1.05 billion, a 22% drop from the previous year. The situation was particularly stark in the fourth quarter, with revenue falling 24% year-over-year to $236.8 million. This culminated in a full-year net loss attributable to common stockholders of $94.9 million, a dramatic swing from a $14.6 million loss in 2024.
In a statement, Co-Founder, Chairman, and CEO Kevin C. Clark acknowledged the difficulties, attributing the performance to a “challenging market backdrop, particularly for travel staffing” and the impact of a “protracted merger process.”
An Industry Cooldown
Cross Country's results reflect a broader normalization across the healthcare staffing industry after the unprecedented demand seen during the COVID-19 pandemic. According to Staffing Industry Analysts (SIA), the overall healthcare staffing market was projected to contract by 6% in 2025. The travel nurse segment, a core business for Cross Country, faced the steepest correction, with market revenue expected to have declined by double digits as hospitals reduced their reliance on high-cost temporary staff.
Cross Country’s segment data clearly illustrates this trend. Its largest division, Nurse and Allied Staffing, saw revenue plummet 25% for the full year to $862.8 million. The average number of field contract personnel on a full-time equivalent (FTE) basis dropped from 8,205 in 2024 to 6,784 in 2025, while the average revenue generated per FTE per day also decreased. This aligns with market data showing a significant year-over-year drop in open travel nursing and allied health positions as the market stabilizes.
Even the Physician Staffing (locum tenens) segment, identified by industry analysts as a growth area, was not immune to challenges within the company, with its revenue declining 4% for the year. This contrasts with the broader market, which saw growth driven by persistent physician shortages.
The Financial Toll of a Failed Merger
While market headwinds were a major factor, Cross Country’s bottom line was hit hardest by a massive, non-cash impairment charge directly linked to the termination of its merger agreement with rival Aya Healthcare. The company recorded a net loss of $82.9 million in the fourth quarter alone, primarily driven by a $77.9 million goodwill and trade name impairment charge.
The press release explicitly states this impairment was “primarily triggered by the fourth quarter decline in the Company’s equity market capitalization following the termination of the Aya Merger Agreement.” Essentially, the collapse of the deal and the subsequent drop in its stock price forced the company to write down the value of its assets.
This charge, along with a $29.6 million valuation allowance against deferred tax assets, overshadowed the $20 million termination fee Cross Country received from Aya as part of the breakup. While this fee boosted operating cash flow for the quarter, the goodwill write-down delivered a much larger blow to the company's net income.
A Pivot to Technology and Efficiency
Despite the grim financial results, CEO Kevin C. Clark projected confidence, stating, “As we enter 2026 unencumbered and laser focused, I’m encouraged, not just by the signs of an improving market, but also by the returns from the investments and actions we have taken already.”
The centerpiece of this new focus is Intellify®, the company’s proprietary, AI-powered workforce management platform. Cross Country is positioning Intellify® as its primary engine for growth, highlighting that 95% of its managed service provider (MSP) and vendor-neutral clients are now live on the platform, which processed 5.7 million hours in 2025. This strategy aligns with a major industry trend, as staffing firms increasingly compete on technology to offer clients greater efficiency and transparency in managing labor costs.
Complementing the tech push is a significant cost-restructuring effort. The company reported it had reduced its US headcount by 21% in 2025, shifting functions to a newly established “India center of excellence” to drive savings. These actions aim to create a leaner operational model better suited to the current market's tighter margins.
The Fortress Balance Sheet
A crucial element underpinning the company's turnaround strategy is its exceptionally strong balance sheet. At the end of 2025, Cross Country held $108.7 million in cash and cash equivalents with zero debt. This financial stability provides a powerful cushion, giving the company the flexibility to weather the current industry downturn and fund its strategic initiatives without being beholden to creditors.
This strength allowed the company to return capital to shareholders, repurchasing over 800,000 shares of its common stock for $6.5 million in the fourth quarter. Management's willingness to execute buybacks, even amidst operating losses, signals a belief that its stock is undervalued and reflects confidence in the long-term plan.
Looking ahead, the company has set ambitious goals. Clark stated, “Our goal is to exit the year at a revenue run-rate north of $1 billion and a profit margin between four and five percent.” The official guidance for the first quarter of 2026 projects revenue to be relatively flat sequentially at $235 million to $240 million, with an adjusted EBITDA margin hovering around 2%. Achieving the CEO's year-end target will require a significant acceleration in profitability as 2026 progresses. Investors will be watching closely to see if the company’s strategic bets on technology and efficiency can restore profitability in the year ahead.
